EUVIMEDEUVIMED entdecken
Vergleichsstudie

Fludarabine Melphalan, Reduced-dose Busulfan Versus Fludarabine, Melphalan, Full-dose Busulfan in Patients Receiving Cord Blood Transplantation

Nana Arai, Hinako Narita, Kai Kuroiwa, Kazuki Nagao, Hidenori Hayashi, Natsuki Kawamata, Reiko Okamura, Yohei Sasaki, Shotaro Shimada, Megumi Watanuki, Yukiko Kawaguchi, Kouji Yanagisawa und 1 weitere

Transplantation Proceedings · 2024

DOI: 10.1016/j.transproceed.2024.08.031 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Transplantation Proceedings, 2024. Verfasst von Nana Arai und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Hematology, Showa University School of Medicine, Shinagawa-Ku, Tokyo, Japan. Hauptthemen laut MEDLINE: Busulfan, Vidarabine, Melphalan, Cord Blood Stem Cell Transplantation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BusulfanVidarabineMelphalanCord Blood Stem Cell TransplantationTransplantation ConditioningHumansRetrospective StudiesFemaleAdultMaleMiddle AgedYoung AdultAgedAdolescent

Substanzen

BusulfanVidarabinefludarabineMelphalan

Autor:innen und Institutionen

  • Department of Medicine, Division of Hematology, Showa University School of Medicine, Shinagawa-Ku, Tokyo, Japan.
  • Department of Medicine, Division of Hematology, Showa University School of Medicine, Shinagawa-Ku, Tokyo, Japan. Electronic address: nhattor@med.showa-u.ac.jp.

Zitieren

APA

Arai, N., Narita, H., Kuroiwa, K., Nagao, K., Hayashi, H., Kawamata, N., Okamura, R., Sasaki, Y., Shimada, S., Watanuki, M., Kawaguchi, Y., Yanagisawa, K., & Hattori, N. (2024). Fludarabine Melphalan, Reduced-dose Busulfan Versus Fludarabine, Melphalan, Full-dose Busulfan in Patients Receiving Cord Blood Transplantation. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2024.08.031

Vancouver

Arai N, Narita H, Kuroiwa K, Nagao K, Hayashi H, Kawamata N, et al. Fludarabine Melphalan, Reduced-dose Busulfan Versus Fludarabine, Melphalan, Full-dose Busulfan in Patients Receiving Cord Blood Transplantation. Transplantation Proceedings. 2024. doi:10.1016/j.transproceed.2024.08.031

BibTeX
@article{Arai2024,
  author = {Arai, Nana and Narita, Hinako and Kuroiwa, Kai and Nagao, Kazuki and Hayashi, Hidenori and Kawamata, Natsuki and Okamura, Reiko and Sasaki, Yohei and Shimada, Shotaro and Watanuki, Megumi and Kawaguchi, Yukiko and Yanagisawa, Kouji and Hattori, Norimichi},
  title = {Fludarabine Melphalan, Reduced-dose Busulfan Versus Fludarabine, Melphalan, Full-dose Busulfan in Patients Receiving Cord Blood Transplantation},
  journal = {Transplantation Proceedings},
  year = {2024},
  doi = {10.1016/j.transproceed.2024.08.031}
}
Kostenlos starten →